Combining targeted therapies

被引:0
|
作者
Xabier García-Albeniz
Alejandro Martinez-Fernandez
Pere Gascon
机构
[1] University of Barcelona,Division of Medical Oncology, Clinic University Hospital, IDIBAPS
[2] ICMHO,Division of Medical Oncology
来源
Targeted Oncology | 2007年 / 2卷
关键词
Targeted therapies; Cetuximab; Trastuzumab; Bevacizumab; Panitumumab; Imatinib; Erlotinib; Gefitinib; Sorafenib; Sunitinib; Lapatinib;
D O I
暂无
中图分类号
学科分类号
摘要
Therapeutics in oncology are rapidly changing, with the advent of the so-called “targeted drugs.” A clear example is trastuzumab, an anti-HER2 monoclonal antibody, and its role in the treatment of breast cancer. Trastuzumab was followed by other monoclonal antibodies like cetuximab (anti-EGFR) and bevacizumab (anti-VEFG) and by tyrosine kinase inhibitors such as imatinib, gefitinib (anti-EGFR) and others. The complex biology of the cancer cell leads us to search combination strategies to act simultaneously in different points of signals transduction pathways to enhance the anticancer effect. Here we review various clinical trials and also experimental data exploring these new drugs in combination. Combination with chemotherapy is beyond the scope of this review. For this review, we have selected the following agents: cetuximab, trastuzumab, bevacizumab, panitumumab, imatinib, erlotinib, gefitinib, sorafenib, sunitinib, and lapatinib.
引用
收藏
页码:241 / 252
页数:11
相关论文
共 50 条
  • [31] Targeted sessions for targeted therapies at ASCO
    Henry, David H.
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (06): : 195 - 196
  • [32] Combining targeted therapies to enhance the effectiveness of chemotherapy in patients with treatment-refractory colorectal cancer
    Eng, Cathy
    CLINICAL COLORECTAL CANCER, 2007, 6 : S53 - S59
  • [33] Next-Generation Medicine: Combining BCR-ABL and Hedgehog-Targeted Therapies
    Dao, Kim-Hien T.
    Tyner, Jeffrey W.
    CLINICAL CANCER RESEARCH, 2013, 19 (06) : 1309 - 1311
  • [34] Receptor targeted therapies
    Baselga, J.
    EJC SUPPLEMENTS, 2004, 2 (03): : 62 - 62
  • [35] Oral targeted therapies
    Etienne-Selloum, Nelly
    ACTUALITES PHARMACEUTIQUES, 2018, 57 (578): : 13 - 18
  • [36] Targeted cancer therapies
    Saurabh Aggarwal
    Nature Reviews Drug Discovery, 2010, 9 : 427 - 428
  • [37] Targeted therapies and radiotherapy
    Hennequin, C
    Giocanti, N
    Favaudon, V
    BULLETIN DU CANCER, 2005, 92 (12) : 1085 - 1092
  • [38] Targeting targeted therapies
    Shingler, William
    Harrop, Richard
    IMMUNOTHERAPY, 2010, 2 (06) : 745 - 748
  • [39] Targeted Therapies in Melanoma
    Moschos, Stergios J.
    Pinnamaneni, Ramya
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 24 (02) : 347 - +
  • [40] Oxaliplatin and targeted therapies
    Ducreux, M
    Malka, D
    Boige, V
    BULLETIN DU CANCER, 2006, 93 : S59 - S63